Viagra had no impact on saquinavir pharmacokinetics. A more robust CYP3A4 inhibitor such as ketoconazole or itraconazole may be envisioned to acquire increased impact than that found with saquinavir. Populace pharmacokinetic information from people in clinical trials also indicated a discount in sildenafil clearance when it was co-administered with